Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where V.G. Malathi is active.

Publication


Featured researches published by V.G. Malathi.


Biochimica et Biophysica Acta | 1971

Effects of murine viral leukemia on spleen nucleoside deaminase: Purification and properties of the enzyme from leukemic spleen☆

V.G. Malathi; Robert Silber

Abstract A 400-fold increase was observed in the specific activity of nucleoside deaminase (cytidine aminohydrolase, EC 3.5.4.5) in the spleen of mice infected with Friend murine leukemia virus. The enzyme was purified 100-fold from the spleen of leukemic mice. It was sensitive to SH reagents and stimulated by dithiothreitol and GSH. Different pH responses were observed in the presence or absence of dithiothreitol. Cytidine was deaminated at a greater rate than deoxycytidine; cytosine or its nucleotides were not deaminated. The molecular weight determined by gel filtration was 74 000.


Methods in Enzymology | 1978

[53] Cytidine deaminase from leukemic mouse spleen

Ivan K. Rothman; V.G. Malathi; Robert Silber

Publisher Summary This chapter describes the purification procedure of cytidine deaminase enzyme from leukemic mouse spleen. Cytidine deaminase is widely distributed among mammalian tissues. This enzyme is responsible for the inactivation of cytosine arabinoside––one of the most useful chemotherapeutic agents available for the treatment of acute myeloblastic leukemia. In the mouse spleen, a marked increase in the specific activity of cytidine deaminase occurs following infection with Friend leukemia virus. Elevated levels of cytidine deaminase are also found in regenerating mouse liver, in human leukemic cells, following the treatment of the patient with cytosine arabinoside, and in HeLa cells cultured in the presence of cytosine arabinoside. The activity of cytidine deaminase is assayed by measuring the amount of labeled uridine formed by the deamination of 2-14C-labeled cytidine. High levels of cytidine deaminase are found in human polymorphonuclear leukocytes.


Biochemical and Biophysical Research Communications | 1979

An Artemia salina factor which counteracts the mRNA-induced inhibition of initiator Met-tRNA binding to initiation factor eIF-2.

V.G. Malathi; Rajarshi Mazumder

Abstract Ternary complex formation between eukaryotic initiation factor 2 (eIF-2), initiator Met-tRNA and guanosine 5′-(β, γ-imino) triphosphate [GMP-P(NH)P] is strongly inhibited by mRNA in the Artemia salina system. Developing A. salina embryos contain a factor which displays a novel activity, namely the ability to counteract the mRNA-induced inhibition of ternary complex formation. This factor is heat-labile. It is proposed that the factor may play an important role in protein biosynthesis by preventing mRNA from inhibiting an early step of peptide chain initiation.


Biochemical and Biophysical Research Communications | 1980

Stimulation of an Artemia salina ATPase activity by eukaryotic messenger RNAs

V.P. Mohan; V.G. Malathi; Rajarshi Mazumder

Summary Several ‘capped’ mRNAs (e.g., 9S globin mRNA) as well as ‘noncapped’ mengo viral mRNA greatly stimulate the activity of a novel ATPase isolated from Artemia salina embryos. Other RNAs tested [tRNAs, initiator Met-tRNA, poly r(U), poly r(A)] are much less stimulatory. The ATPase activity is also stimulated by mRNAs in the presence of 40S ribosomal subunits. However, the other RNAs listed above are inhibitory under the latter conditions. The ATPase activity is strongly stimulated by 40S ribosomal subunits in the absence of mRNAs. It is suggested that the ATPase, described here, might be involved in the binding of natural eukaryotic mRNAs to 40S peptide chain preinitiation complexes, a process known to depend on ATP hydrolysis.


Biochimica et Biophysica Acta | 1978

An inhibitor which interferes with the enzymatic aminoacylation of tRNA.

V.G. Malathi; Rajarshi Mazumder

Inactive, frozen and thawed cytoplasmic extracts of 3T3 and SV-101 (3T3 transformed by SV-40 virus) cells contain an inhibitor which blocks the poly(U)-directed incorporation of [14C]phenylalanine into polypeptides, catalyzed by active extracts of these cells. This inhibition is not reversed by adding increased amounts of poly(U). Furthermore, little or no inhibitory activity is observed when poly(U) translation is assayed using precharged [14C]Phe-tRNA. These results suggest that the observed inhibition is not due to the degradation of poly(U) by a nuclease. The inhibitor appears to act primarily at the level of tRNA charging since the synthesis of both Phe-tRNA and Lys-tRNA is impaired in its presence. Evidence is presented which indicates that the inhibitory activity is not due to a high molecular weight protein or nucleic acid. However, the inhibitor appears to be adsorbed to a macromolecule. The inhibitory activity is completely destroyed by ashing.


Proceedings of the National Academy of Sciences of the United States of America | 1972

Purification and Properties of Bacteriophage T4-Induced RNA Ligase

Robert Silber; V.G. Malathi; Jerard Hurwitz


Journal of Biological Chemistry | 1974

Studies on Ribonucleic Acid Ligase CHARACTERIZATION OF AN ADENOSINE TRIPHOSPHATE-INORGANIC PYROPHOSPHATE EXCHANGE REACTION AND DEMONSTRATION OF AN ENZYME-ADENYLATE COMPLEX WITH T4 BACTERIOPHAGE-INDUCED ENZYME

Joseph W. Cranston; Robert Silber; V.G. Malathi; Jerard Hurwitz


Journal of Biological Chemistry | 1973

Studies on Nucleoside Deaminase INCREASE IN ACTIVITY IN HELA CELL CULTURES CAUSED BY CYTOSINE ARABINOSIDE

Rose Meyers; V.G. Malathi; Rody P. Cox; Robert Silber


Cancer Research | 1971

Nucleoside Deaminase Activity in Viral Leukemia

Ivan K. Rothman; V.G. Malathi; Robert Silber


Workshop on Mechanisms and Prospects of Genetic Exchange, Berlin, December 11 to 13, 1971#R##N#Advances in The Biosciences | 1972

Studies on Transcription and Ligation of RNA

Jonathan Leis; Robert Silber; V.G. Malathi; Jerard Hurwitz

Collaboration


Dive into the V.G. Malathi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jerard Hurwitz

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge